BR0110232A - Vacina para mioencefalite equina causada por protozoário - Google Patents

Vacina para mioencefalite equina causada por protozoário

Info

Publication number
BR0110232A
BR0110232A BR0110232-0A BR0110232A BR0110232A BR 0110232 A BR0110232 A BR 0110232A BR 0110232 A BR0110232 A BR 0110232A BR 0110232 A BR0110232 A BR 0110232A
Authority
BR
Brazil
Prior art keywords
protozoan
vaccine
myencephalitis
equine
derived therefrom
Prior art date
Application number
BR0110232-0A
Other languages
English (en)
Inventor
Rocky Barry Bigbie
Terry Kaleung Ng
Joseph Wilson Whalen Jr
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0110232A publication Critical patent/BR0110232A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/947—Microorganisms using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"VACINA PARA MIOENCEFALITE EQuINA CAUSADA POR PROTOZOáRIO". A presente invenção fornece um componente imunogenicamente ativo que compreende células inativadas de Sarcocystis neurona e/ou células inativadas de Neospora hughesi; antígenos derivados das mesmas; DNA derivado das mesmas; ou uma mistura; ou em combinação com outros componentes de vacina das mesmas. São ainda fornecidas composições para vacinas úteis para a prevenção ou para a melhora da infecção e da doença mioencefalite causada por protozoários e um processo para a propagação da cultura de células de parasitas protozoários.
BR0110232-0A 2000-04-25 2001-04-13 Vacina para mioencefalite equina causada por protozoário BR0110232A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19943500P 2000-04-25 2000-04-25
US27869501P 2001-03-26 2001-03-26
PCT/US2001/040527 WO2001080885A2 (en) 2000-04-25 2001-04-13 Equine protozoal myeloencephalitis vaccine

Publications (1)

Publication Number Publication Date
BR0110232A true BR0110232A (pt) 2003-01-21

Family

ID=26894769

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110232-0A BR0110232A (pt) 2000-04-25 2001-04-13 Vacina para mioencefalite equina causada por protozoário

Country Status (7)

Country Link
US (2) US7169398B2 (pt)
EP (1) EP1276499A2 (pt)
AR (1) AR035182A1 (pt)
AU (1) AU2001251761A1 (pt)
BR (1) BR0110232A (pt)
CA (1) CA2407517A1 (pt)
WO (1) WO2001080885A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1276499A2 (en) * 2000-04-25 2003-01-22 Wyeth Equine protozoal myeloencephalitis vaccine
WO2003099325A1 (en) 2002-05-21 2003-12-04 Schering-Plough Ltd. Methods for the in vitro culture of sporozoea sp. and user thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07501797A (ja) * 1991-11-12 1995-02-23 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ライム病に対する組換えワクチン
EP0630234B1 (en) * 1992-03-12 1997-06-11 Alkermes Controlled Therapeutics, Inc. Controlled release acth containing microspheres
US6514697B1 (en) * 1992-05-29 2003-02-04 The Regents Of The University Of California Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6110665A (en) * 1995-02-14 2000-08-29 University Of Kentucky Research Foundation Sarcocystis neuronadiagnostic primer and its use in methods of equine protozoal myeloencephalitis diagnosis
GB2310212A (en) * 1996-02-16 1997-08-20 Jose Luis Azumendi Isolation of the sarcocystine toxin from the genus Sarcocystis
WO1997029120A1 (en) * 1996-02-05 1997-08-14 Sarco Research Corporation Limited Sarcocystine isolation
GB2310135A (en) * 1996-02-16 1997-08-20 Jose Luis Azumendi Sarcocystis vaccine:lyophilized bradyzoites
US5958414A (en) * 1997-09-03 1999-09-28 Heska Corporation Composition to protect a mammal against Bartonella henselae infection
US6071737A (en) * 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses
US7056517B2 (en) * 1998-04-13 2006-06-06 The Forsyth Institute Glucosyltransferase immunogens
US7163682B2 (en) * 1998-04-13 2007-01-16 The Forsyth Institute Glucan binding protein and glucosyltransferase immunogens
US6153394A (en) 1998-09-18 2000-11-28 Board Of Trustees Operating Michigan State University Immunoassay for equine protozoal myeloencephalitis in horses
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
CA2359075A1 (en) 1999-02-19 2000-08-24 Michigan State University An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid
US6737237B1 (en) * 1999-05-04 2004-05-18 Apicomplexan Therapeutics, Llc Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components
AU7108700A (en) * 1999-09-02 2001-03-26 Michigan State University Vaccine to control equine protozoal myeloencephalitis in horses
US20070172502A1 (en) * 2000-02-07 2007-07-26 David Bzik Compositions and methods for treatment of Toxoplasma gondii and other apicomplexans
EP1276499A2 (en) * 2000-04-25 2003-01-22 Wyeth Equine protozoal myeloencephalitis vaccine
US7342101B1 (en) * 2003-12-01 2008-03-11 The University Of Texas System Board Of Regents Compositions and methods comprising a protective antigen of Coccidiodes immitis

Also Published As

Publication number Publication date
US20020041886A1 (en) 2002-04-11
AR035182A1 (es) 2004-05-05
EP1276499A2 (en) 2003-01-22
AU2001251761A1 (en) 2001-11-07
CA2407517A1 (en) 2001-11-01
US7169398B2 (en) 2007-01-30
WO2001080885A2 (en) 2001-11-01
US20070104739A1 (en) 2007-05-10
WO2001080885A3 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
ES2129386T1 (es) Vacuna contra influenza.
BR0306993A (pt) Polìmero de polialquilenoglicol ativado; composição farmacêutica; método para tratar um paciente que tem uma infecção viral suscetìvel; e método para tratar um paciente suspeito de ter infecção por hepatite c
ES2156110T3 (es) Analogos de sub-unidades de toxina del colera derivados de adn recombinante.
BRPI0510928A (pt) identificação de organismos viralmente infectados e vacinados
BR0009157A (pt) Vacina e antìgeno de staphylococcus
BRPI0407636A (pt) meio de cultura de células, linhagem de células animais, métodos para produzir um meio de cultura condicionado, células animais, uma cultura de células animais, vìrus em uma cultura de células animais, ou, de preferência, humanas diplóides dependentes de ancoragem, método para produzir uma vacina, e, população de vìrus
BR0208301A (pt) Vacinas de ácido nucléico para prevenção de infecção por flavivìrus
BRPI0208456B8 (pt) métodos para cultura de circovírus
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
PT891420E (pt) Processos para a replicacao dos virus influenza numa cultura celular e os virus influenza que se podem obter atraves do processo
BR122019013216B8 (pt) ensaio imunológico para análise de uma vacina contra influenza
EP1071827A4 (en) DIAGNOSTIC SYSTEMS BASED ON CULTURES OF MIXED CELLS
Murthy et al. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele
PT745388E (pt) Composicao de vacinas para mamiferos compreendendo esqualeno ou esqualano fosfolipido e um tensioactivo como adjevante
ATE306938T1 (de) Verwendung von cpg als adjuvans für hivimpstoff
SE8703225L (sv) Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner
BR0204920A (pt) Uso de silicones aminados particulares em pré-tratamento de colorações diretas ou de oxidação de fibras queratìnicas e processo de coloração das mesmas
ES2097759T3 (es) Anticuerpos especificos para el dominio de fijacion de cd4 de hiv.
BR9610343A (pt) Vacinas de subtipos múltiplos para fiv
BR0009640A (pt) Vìrus de herpes recombinantes e mutantes
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
BR9806971A (pt) Epìtopes de célula t universal para vacinas anti-malária.
TR200100948T2 (tr) Cinsel yoldan bulaşan hastalıklara karşı aşı
BR0112497A (pt) Antìgenos de streptococcus pyogenes
ES2194097T3 (es) Composiciones de fosfolipidos modificados con silicona.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.